Early and Late Complications of COVID-19
Characteristics and Predictors of Early and Late Cardiovascular Complications of Covid-19 Patients - the PoLoCOV-Study (Polish LONG-COVID Cardiovascular Study)
1 other identifier
observational
1,900
1 country
1
Brief Summary
Coronavirus disease 2019 (COVID-19) is a serious respiratory disease that results from infection with a newly discovered coronavirus (SARS-COV-2). Unfortunately, COVID-19 is not only a short-term infection. Patients (pts) recovering from SARS-COV2 infection complain of persisting symptoms including: fatigue, diffuse myalgia and weakness, which may lead to chronic fatigue syndrome and as well as many other complications. The vast majority of COVID-19 patients remaining in isolation/quarantine, due to the mild course of the disease, do not require hospitalization. In this group of patients, the course of COVID-19 is very different - from asymptomatic patients to very severe and long lasting symptoms also with a decrease in saturation. There are many studies describing the course and complications of patients hospitalized due to COVID-19. There is little published data on how non-hospitalized patients get sick and what are the early and late complications of SARS-CoV-2 infection. In addition, many patients remain ill even many months after COVID-19, entering what is known as LONG-COVID. Therefore, the STOP-COVID Registry was established. The purpose of the Registry is to assess the course of COVID-19 infection, early and late cardiovascular complications of COVID-19 in patients with and without hospitalization. In addition, the purpose of the STOP-COVID Registry is to assess the incidence of LONG-COVID with all other complications and to identify predictive factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 29, 2020
CompletedFirst Submitted
Initial submission to the registry
August 23, 2021
CompletedFirst Posted
Study publicly available on registry
August 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedAugust 24, 2021
August 1, 2021
2.3 years
August 23, 2021
August 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Early and Late COVID-19 cardio-vascular complications
Early and Late COVID-19 cardio-vascular complications
5 years
Predictors of Long-Covid Cardio-Vascular complications
Predictors of Long-Covid Cardio-Vascular complications
5 years
SCORE - algorithm to help to predict the highest risk of Long-Covid complications
SCORE - algorithm to help to predict the highest risk of Long-Covid complications
5 years
Secondary Outcomes (3)
Detailed patients' characteristics and differences in those with and without Long-Covid complications
5 years
Definition and characteristics of the early and Late COVID-19 complications
5 years
Comparison of complications and Long-Covid depending on the severity of the course of COVID-19 COVID-19, comorbidities
5 years
Eligibility Criteria
Patients 18 years and older diagnosed with COVID-19, after full recovery (resolution of clinical symptoms, minimum 14 days after last symptoms), with and without hospitalization .
You may qualify if:
- Patients after COVID-19, 18 years and older
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Michal Chudziklead
Study Sites (1)
Medical Center, Saint Family Hospital
Lodz, 90-302, Poland
Related Publications (2)
Babicki M, Kapusta J, Kolat D, Kaluzinska-Kolat Z, Mastalerz-Migas A, Jankowski P, Chudzik M. Cardiac symptoms in patients 3-6 months after contracting COVID-19- data from the polish STOP-COVID registry. BMC Infect Dis. 2025 Apr 9;25(1):489. doi: 10.1186/s12879-025-10774-0.
PMID: 40205590DERIVEDKapusta J, Chudzik M, Kaluzinska-Kolat Z, Kolat D, Burzynska M, Jankowski P, Babicki M. Do selected lifestyle parameters affect the severity and symptoms of COVID-19 among elderly patients? The retrospective evaluation of individuals from the STOP-COVID registry of the PoLoCOV study. J Infect Public Health. 2023 Jan;16(1):143-153. doi: 10.1016/j.jiph.2022.12.008. Epub 2022 Dec 12.
PMID: 36521330DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medical Doctor, Cardiologist, Medical Director Ambulatory Clinic
Study Record Dates
First Submitted
August 23, 2021
First Posted
August 24, 2021
Study Start
May 29, 2020
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
August 24, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share